We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL41 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
8137.3
Number of samples
349
Samples
Sample
Description
TPM
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
26614.3
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
19847.1
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
18931.0
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
18602.2
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
17884.3
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
17321.6
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
17195.0
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
16943.9
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
16941.2
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
16008.4
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
15940.5
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
15847.1
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
15751.4
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
15518.9
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
15301.9
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
15295.3
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
14890.6
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
14445.6
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
14348.7
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
14326.6
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
14272.1
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
14224.8
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
14197.6
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
13994.1
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
13979.7
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
13787.0
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
13725.6
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
13646.0
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
13550.2
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
13505.0
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
13429.4
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
13411.9
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
13381.2
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
13342.1
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
13178.1
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
13174.7
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
12726.1
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
12659.9
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
12406.3
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
12399.5
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
12391.5
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
12270.4
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
12180.8
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
11944.6
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
11913.6
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
11691.4
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
11556.2
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
11552.7
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
11551.7
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
11503.2
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
11193.1
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
11181.5
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
11175.1
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
11161.9
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
11119.9
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
11066.0
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
11039.8
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
11004.4
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
10895.0
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
10848.7
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
10825.4
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
10737.1
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
10726.8
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
10661.7
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
10569.7
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
10537.5
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
10534.0
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
10510.2
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
10468.8
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
10456.6
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
10451.5
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
10441.1
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
10426.0
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
10423.9
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
10422.7
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
10418.2
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
10294.9
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
10227.0
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
10215.5
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
10153.2
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
10122.5
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
10108.1
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
10090.7
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
10070.4
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
10022.2
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
9913.2
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
9899.4
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
9869.4
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
9841.0
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
9829.7
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
9780.1
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
9769.4
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
9593.5
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
9581.9
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
9567.3
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
9516.2
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
9511.0
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
9485.9
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
9469.5
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
9450.7
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
9440.1
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
9393.9
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
9359.6
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
9351.1
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
9348.6
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
9325.6
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
9307.6
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
9307.2
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
9282.0
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
9196.5
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
9188.8
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
9142.9
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
9142.8
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
9109.2
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
9079.8
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
9040.1
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
8997.1
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
8931.3
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
8830.9
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
8820.7
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
8816.7
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
8757.4
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
8752.0
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
8698.1
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
8687.9
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
8682.4
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
8678.4
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
8647.6
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
8541.0
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
8529.3
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
8489.4
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
8458.9
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
8418.7
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
8407.2
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
8396.6
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
8379.0
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
8373.8
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
8366.1
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
8332.3
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
8300.1
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
8289.9
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
8275.5
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
8267.7
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
8250.0
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
8246.5
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
8244.0
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
8229.4
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
8115.4
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
8076.5
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
8074.6
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
8060.5
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
8037.1
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
8029.6
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
8015.6
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
7959.2
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
7931.9
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
7924.8
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
7922.8
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
7884.5
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
7877.4
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
7877.0
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
7871.4
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
7863.1
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
7859.7
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
7814.2
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
7811.7
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
7805.4
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
7764.0
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
7720.9
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
7717.5
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
7666.9
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
7659.3
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
7621.4
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
7605.0
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
7589.7
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
7569.9
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
7492.8
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
7427.8
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
7425.9
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
7424.9
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
7417.2
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
7388.8
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
7312.9
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
7311.7
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
7261.7
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
7256.6
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
7244.6
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
7241.2
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
7222.1
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
7205.4
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
7160.7
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
7118.8
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
7114.2
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
7089.7
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
7048.1
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
7047.7
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
7039.5
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
7035.5
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
6968.9
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
6966.6
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
6964.3
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
6956.7
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
6913.8
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
6856.7
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
6849.5
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
6818.8
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
6811.0
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
6782.7
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
6781.7
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
6734.0
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
6714.7
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
6704.6
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
6696.6
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
6685.8
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
6666.7
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
6591.4
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
6564.9
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
6559.9
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
6556.0
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
6546.6
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
6498.3
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
6492.1
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
6478.3
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
6473.8
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
6469.3
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
6466.5
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
6433.1
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
6424.7
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
6396.7
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
6391.3
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
6326.3
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
6301.9
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
6255.8
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
6225.5
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
6204.7
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
6203.7
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
6202.1
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
6188.9
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
6122.5
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
6090.2
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
6063.0
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
6055.2
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
6054.1
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
6030.3
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
6012.6
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
5986.2
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
5984.0
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
5976.9
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
5912.5
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
5906.0
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
5876.2
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
5841.7
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
5840.1
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
5821.1
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
5777.8
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
5750.7
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
5738.4
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
5723.1
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
5715.2
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
5709.5
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
5684.8
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
5683.6
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
5679.4
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
5660.4
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
5611.6
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
5591.3
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
5564.8
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
5547.6
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
5543.5
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
5536.7
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
5535.3
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
5518.9
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
5510.4
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
5493.1
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
5493.0
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
5485.5
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
5483.6
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
5452.9
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
5423.6
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
5341.3
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
5305.5
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
5215.7
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
5182.3
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
5180.1
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
5168.0
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
5147.7
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
5131.3
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
5129.5
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
5126.4
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
5107.5
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
5094.1
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
5077.0
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
5074.8
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
5038.2
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
5037.6
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
5017.8
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
5000.8
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
4992.4
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
4855.9
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
4849.7
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
4843.8
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
4841.2
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
4808.6
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
4784.7
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
4777.1
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
4773.2
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
4729.5
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
4728.2
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
4711.5
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
4690.3
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
4686.1
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
4670.3
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
4628.7
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
4568.0
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
4538.0
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
4486.5
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
4466.4
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
4359.8
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
4340.8
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
4323.9
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
4316.6
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
4222.0
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
4139.6
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
4118.0
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
4034.7
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
3870.2
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
3841.6
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
3799.9
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
3780.0
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
3774.0
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
3749.7
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
3736.6
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
3710.5
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
3648.5
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
3576.5
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
3541.2
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
3429.5
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
3393.2
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
3364.2
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
3173.2
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
3104.6
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
3098.0
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
3003.8
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
2993.9
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
2864.2
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
2839.1
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
2768.8
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
2737.6
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL41 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
7192.8
Number of samples
81
Samples
Sample
Description
TPM
DO46356
68 years, female, NA, stage:III, dead, 911 days
17182.9
DO46591
58 years, female, NA, stage:III, dead, 195 days
14136.6
DO46576
75 years, female, NA, stage:III, alive, 133 days
14074.7
DO46370
54 years, female, NA, stage:III, dead, 1727 days
14065.2
DO46384
55 years, female, NA, stage:III, dead, 614 days
13248.2
DO46390
65 years, female, NA, stage:III, dead, 374 days
12900.9
DO46378
59 years, female, NA, stage:III, alive, 843 days
11738.4
DO46352
60 years, female, NA, stage:III, dead, 677 days
11638.1
DO46412
64 years, female, NA, stage:III, dead, 597 days
10994.9
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
10952.0
DO46568
66 years, female, NA, stage:III, dead, 320 days
10771.7
DO46333
58 years, female, NA, stage:III, dead, 359 days
10495.4
DO46402
77 years, female, NA, stage:III, dead, 511 days
10413.2
DO46463
49 years, female, NA, stage:III, dead, 2451 days
9929.1
DO46453
66 years, female, NA, stage:III, dead, 3294 days
9868.7
DO46338
59 years, female, NA, stage:III, dead, 596 days
9135.9
DO46561
52 years, female, NA, stage:III, dead, 195 days
9063.9
DO46334
77 years, female, NA, stage:III, dead, 496 days
9035.6
DO46606
73 years, female, NA, stage:III, alive, 804 days
8961.2
DO46330
60 years, female, NA, stage:III, dead, 684 days
8905.5
DO46326
51 years, female, NA, stage:III, dead, 701 days
8648.9
DO46468
67 years, female, NA, stage:III, alive, 2776 days
8619.7
DO46566
78 years, female, NA, stage:III, dead, 673 days
8604.0
DO46328
52 years, female, NA, stage:III, dead, 972 days
8443.7
DO46346
54 years, female, NA, stage:III, dead, 1187 days
8327.1
DO46366
65 years, female, NA, stage:III, dead, 2054 days
8294.8
DO46586
55 years, female, NA, stage:III, dead, 1019 days
8055.0
DO46518
62 years, female, NA, stage:III, alive, 2960 days
7939.6
DO46364
45 years, female, NA, stage:III, dead, 806 days
7902.5
DO46581
66 years, female, NA, stage:III, dead, 408 days
7820.3
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
7766.3
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
7635.0
DO46380
51 years, female, NA, stage:III, dead, 1423 days
7386.0
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
7302.1
DO46358
60 years, female, NA, stage:III, dead, 423 days
7137.9
DO46386
49 years, female, NA, stage:III, dead, 1162 days
7131.6
DO46404
55 years, female, NA, stage:III, dead, 690 days
7122.4
DO46597
60 years, female, NA, stage:III, dead, 393 days
7027.7
DO46342
67 years, female, NA, stage:III, dead, 1398 days
6976.9
DO46538
57 years, female, NA, stage:III, dead, 1527 days
6953.0
DO46443
59 years, female, NA, stage:III, dead, 2464 days
6891.1
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
6798.2
DO46560
45 years, female, NA, stage:IV, dead, 286 days
6604.8
DO46408
56 years, female, NA, stage:III, dead, 489 days
6581.2
DO46398
66 years, female, NA, stage:III, alive, 437 days
6501.4
DO46508
50 years, female, NA, stage:III, dead, 2101 days
6472.6
DO46551
58 years, female, NA, stage:III, dead, 1055 days
6459.4
DO46392
48 years, female, NA, stage:III, dead, 628 days
6425.8
DO46362
61 years, female, NA, stage:III, dead, 1639 days
6209.7
DO46350
66 years, female, NA, stage:III, dead, 886 days
6181.8
DO46432
56 years, female, NA, stage:III, alive, 2218 days
6138.6
DO46533
46 years, female, NA, stage:III, alive, 3667 days
6115.8
DO46588
74 years, female, NA, stage:III, dead, 438 days
5886.1
DO46368
57 years, female, NA, stage:III, dead, 2879 days
5843.6
DO46325
54 years, female, NA, stage:III, dead, 477 days
5672.8
DO46374
69 years, female, NA, stage:III, dead, 1409 days
5547.9
DO46329
52 years, female, NA, stage:III, dead, 1699 days
5388.9
DO46493
62 years, female, NA, stage:IV, alive, 839 days
5384.5
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
5285.2
DO46344
46 years, female, NA, stage:III, dead, 642 days
5242.4
DO46340
62 years, female, NA, stage:III, dead, 616 days
5138.5
DO46372
39 years, female, NA, stage:III, dead, 1326 days
5101.9
DO46400
70 years, female, NA, stage:III, dead, 719 days
4981.0
DO46448
45 years, female, NA, stage:III, dead, 654 days
4844.3
DO46396
64 years, female, NA, stage:III, dead, 583 days
4535.1
DO46571
61 years, female, NA, stage:III, dead, 243 days
4366.3
DO46382
62 years, female, NA, stage:IV, dead, 311 days
4183.6
DO46436
58 years, female, NA, stage:III, alive, 3193 days
4156.9
DO46388
74 years, female, NA, stage:III, dead, 413 days
4146.7
DO46336
70 years, female, NA, stage:IV, dead, 664 days
4012.9
DO46528
56 years, female, NA, stage:III, alive, 6139 days
3857.3
DO46332
56 years, female, NA, stage:III, dead, 689 days
3733.4
DO46327
54 years, female, NA, stage:III, dead, 184 days
3567.5
DO46348
58 years, female, NA, stage:IV, dead, 287 days
3558.1
DO46354
73 years, female, NA, stage:III, dead, 843 days
3452.9
DO46611
52 years, female, NA, stage:III, dead, 734 days
3175.5
DO46376
58 years, female, NA, stage:III, dead, 1430 days
2919.2
DO46602
74 years, female, NA, stage:III, dead, 205 days
2885.4
DO46331
72 years, female, NA, stage:III, dead, 612 days
2340.4
DO46546
73 years, female, NA, stage:III, dead, 1889 days
1957.7
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
1470.5
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
N/A
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
N/A
21efd60f-6a31-4b98-9477-16a905_D2
Normal
N/A
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
N/A
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
N/A
285fed94-1495-448e-879b-b55de9_D2
Tumor
N/A
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
N/A
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
N/A
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
N/A
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
N/A
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
N/A
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
N/A
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
N/A
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
N/A
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
N/A
2f901c90-617e-46da-9fac-d68369_D2
Tumor
N/A
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
N/A
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
N/A
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
N/A
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
N/A
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
N/A
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
N/A
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
N/A
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
N/A
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
N/A
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
N/A
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
N/A
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
N/A
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
N/A
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
N/A
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
N/A
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
N/A
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
N/A
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
N/A
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
N/A
1772e913-f62e-446a-8cf3-720348_D2
Tumor
N/A
e9d416e7-f661-400a-896e-388545_D2
Tumor
N/A
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
N/A
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
N/A
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
N/A
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
N/A
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
N/A
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
N/A
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
N/A
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
N/A
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
N/A
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
N/A
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
N/A
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
N/A
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
N/A
10c2d629-0287-4511-ac25-f29031_D2
Tumor
N/A
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
N/A
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
N/A
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
N/A
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
N/A
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
N/A
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
N/A
340a3769-3031-41ae-bb08-a2f696_D2
Normal
N/A
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
N/A
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
N/A
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
N/A
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
N/A
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
N/A
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
N/A
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
N/A
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
N/A
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
N/A
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
N/A
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
N/A
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
N/A
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
N/A
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
N/A
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
N/A
15524912-685a-47ce-a824-567848_D2
Tumor
N/A
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
N/A
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
N/A
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
N/A
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
N/A
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
N/A
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
N/A
a3a26070-fb84-406a-8280-d555e6_D2
Normal
N/A
161317f3-1a39-438e-af45-cd2502_D2
Tumor
N/A
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
N/A
1db5574d-aca7-403c-8100-6e705f_D2
Normal
N/A
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
N/A
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
N/A
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
N/A
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
N/A
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
N/A
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
N/A
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
N/A
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
N/A
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
N/A
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
N/A
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
N/A
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
N/A
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
N/A
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
N/A
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
N/A
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
N/A
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
N/A
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
N/A
a65d8e76-640f-4341-a561-afbb57_D2
Normal
N/A
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
N/A
1a10c200-3895-4648-b951-94f99f_D2
Tumor
N/A
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
N/A
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
N/A
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
N/A
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
